Tregs normally express the GARP receptor encoded by the Lrrc32 gene, which under pathological conditions may increase the oncogenic potential of the tumor and increase the biological activity of TGF-β, and its overexpression induced by cancer may lead to Treg activation [198]. The gene discussed is TGFB1; the disease is neoplasm.